ANGPTL4 anticorps
Aperçu rapide pour ANGPTL4 anticorps (ABIN7260055)
Antigène
Voir toutes ANGPTL4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein of human ANGPTL4 (NP_647475.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000 IF 1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ANGPTL4 (Angiopoietin-Like 4 (ANGPTL4))
-
Autre désignation
- ANGPTL4
-
Sujet
- This gene encodes a glycosylated, secreted protein containing a C-terminal fibrinogen domain. The encoded protein is induced by peroxisome proliferation activators and functions as a serum hormone that regulates glucose homeostasis, lipid metabolism, and insulin sensitivity. This protein can also act as an apoptosis survival factor for vascular endothelial cells and can prevent metastasis by inhibiting vascular growth and tumor cell invasion. The C-terminal domain may be proteolytically-cleaved from the full-length secreted protein. Decreased expression of this gene has been associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4.
-
Poids moléculaire
-
Observed_MW: 44 kDa
Calculated_MW: 26 kDa/40 kDa/45 kDa
-
ID gène
- 51129
-
UniProt
- Q9BY76
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Antigène
-